Porcaro Federica, Ullmann Nicola, Allegorico Annalisa, Di Marco Antonio, Cutrera Renato
Pediatric Pulmonology & Respiratory Intermediate Care Unit, Sleep and Long-Term Ventilation Unit, Academic Department of Pediatrics, and Genetic Research Area, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.
Children (Basel). 2020 Dec 10;7(12):286. doi: 10.3390/children7120286.
Asthma is the most frequent chronic inflammatory disease of the lower airways affecting children, and it can still be considered a challenge for pediatricians. Although most asthmatic patients are symptom-free with standard treatments, a small percentage of them suffer from uncontrolled persistent asthma. In these children, a multidisciplinary systematic assessment, including comorbidities, treatment-related issues, environmental exposures, and psychosocial factors is needed. The identification of modifiable factors is important to differentiate children with difficult asthma from those with true severe therapy-resistant asthma. Early intervention on modifiable factors for children with difficult asthma allows for better control of asthma without the need for invasive investigation and further escalation of treatment. Otherwise, addressing a correct diagnosis of true severe therapy-resistant asthma avoids diagnostic and therapeutic delays, allowing patients to benefit from using new and advanced biological therapies.
哮喘是影响儿童的最常见的下呼吸道慢性炎症性疾病,对儿科医生来说仍是一项挑战。尽管大多数哮喘患者通过标准治疗无症状,但仍有一小部分患者患有未得到控制的持续性哮喘。对于这些儿童,需要进行多学科系统评估,包括合并症、治疗相关问题、环境暴露和社会心理因素。识别可改变因素对于区分难治性哮喘儿童和真正的重度治疗抵抗性哮喘儿童很重要。对难治性哮喘儿童的可改变因素进行早期干预,可在无需进行侵入性检查和进一步强化治疗的情况下更好地控制哮喘。否则,正确诊断真正的重度治疗抵抗性哮喘可避免诊断和治疗延误,使患者能够受益于使用新的先进生物疗法。